| Application no. and date | 03745203.4 (espacenet) (Federated) (European Patent Register), 20030317 | | Patent/reg. no. and date | DK/EP 1487790, 20100303 | | Publication date | 20041222 | | Priority no. and date | US 368872 P, 20020328 | | EP pub. no. and date |
EP 1487790 20041222 | | Effective date | | | Applicant/owner | Pfizer Products Inc., Eastern Point Road
Groton,
Connecticut 06340, US | | Applicant ref. no. | P81001238DK00E | | Inventor | MCLAUGHLIN, Robert William, Pfizer Global Research and Development
Eastern Point Road,
Groton, CT 06340, US,
SKLAVOUNOS, Constantine, 7 East Wharf Road
Waterford, CT 06385, US,
WATSON, Harry Austin, Jr., Pfizer Global Research and Development
Eastern Point Road,
Groton, CT 06340, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | C07D 207/08 (2006.01) | | Title | Renset lasofoxifen og fremgangsmåde til opensning af racemisk lasofoxifen ved omkrystallisering | | Int. application no. | IB2003001033 | | Int. publication no. | WO2003082814 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
